Literature DB >> 16623961

A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients.

Peter R Joyce1, Patrick C McHugh, Janice M McKenzie, Patrick F Sullivan, Roger T Mulder, Suzanne E Luty, Janet D Carter, Christopher M A Frampton, C Robert Cloninger, Allison M Miller, Martin A Kennedy.   

Abstract

BACKGROUND: Borderline personality disorder (BPD) is often co-morbid with major depression and may complicate its treatment. We were interested in differences in genetic and developmental risk factors between depressed patients with or without a co-morbid BPD.
METHOD: Out-patients with major depressive disorder were recruited for two treatment trials. Assessment of depressed patients included the assessment of personality disorders, developmental risk factors and DNA samples for genetic analyses.
RESULTS: In each study there was a significant association between the 9-repeat allele of the dopamine transporter (DAT1) and BPD, with odds ratios (OR) > 3 and p < or = 0.02. This association remained significant when developmental risk factors for BPD (childhood abuse and neglect and borderline temperament) were also included in the analyses. The OR was even larger in the depressed patients aged > or = 35 years (OR 9.31, p = 0.005).
CONCLUSION: This replicated association in depressed patients between the 9-repeat allele of DAT1 and BPD may provide clues to understanding the neurobiology of BPD. The finding that the association is larger in the older depressed patients, suggests that the 9-repeat allele may be associated with a poorer prognosis BPD, rather than a young adult limited variant of BPD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16623961     DOI: 10.1017/S0033291706007288

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

1.  Individual differences in vulnerability for self-injurious behavior: studies using an animal model.

Authors:  Amber M Muehlmann; Jennifer A Wilkinson; Darragh P Devine
Journal:  Behav Brain Res       Date:  2010-10-23       Impact factor: 3.332

Review 2.  Developmental pathways to borderline personality disorder.

Authors:  Andrew M Chanen; Michael Kaess
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

3.  [Contribution of neurobiology to our knowledge of borderline personality disorder].

Authors:  S C Herpertz
Journal:  Nervenarzt       Date:  2011-01       Impact factor: 1.214

4.  A neurochemical hypothesis for the origin of hominids.

Authors:  Mary Ann Raghanti; Melissa K Edler; Alexa R Stephenson; Emily L Munger; Bob Jacobs; Patrick R Hof; Chet C Sherwood; Ralph L Holloway; C Owen Lovejoy
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

Review 5.  The association of bipolar spectrum disorders and borderline personality disorder.

Authors:  Diomidis Antoniadis; Maria Samakouri; Miltos Livaditis
Journal:  Psychiatr Q       Date:  2012-12

Review 6.  Borderline personality disorder: considerations for inclusion in the Massachusetts parity list of "biologically-based" disorders.

Authors:  Mary Ellen Foti; Jeffrey Geller; Laura S Guy; John G Gunderson; Brian A Palmer; Lisa M Smith
Journal:  Psychiatr Q       Date:  2011-06

7.  Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls.

Authors:  Vassilis N Panagopoulos; Timothy J Trull; Anne L Glowinski; Michael T Lynskey; Andrew C Heath; Arpana Agrawal; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Pamela A F Madden; Elizabeth Moore; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery; Elliot C Nelson
Journal:  Drug Alcohol Depend       Date:  2012-12-12       Impact factor: 4.492

8.  Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.

Authors:  Zsofia Nemoda; Karlen Lyons-Ruth; Anna Szekely; Eszter Bertha; Gabor Faludi; Maria Sasvari-Szekely
Journal:  Behav Brain Funct       Date:  2010-01-12       Impact factor: 3.759

Review 9.  A biosocial developmental model of borderline personality: Elaborating and extending Linehan's theory.

Authors:  Sheila E Crowell; Theodore P Beauchaine; Marsha M Linehan
Journal:  Psychol Bull       Date:  2009-05       Impact factor: 17.737

Review 10.  Multifinality in the development of personality disorders: a Biology x Sex x Environment interaction model of antisocial and borderline traits.

Authors:  Theodore P Beauchaine; Daniel N Klein; Sheila E Crowell; Christina Derbidge; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.